FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024890690> ?p ?o ?g. }

• W2024890690 endingPage "14238" @default.
• W2024890690 startingPage "14225" @default.
• W2024890690 abstract "RRAD (Ras-related associated with diabetes) is a small Ras-related GTPase that is frequently inactivated by DNA methylation of the CpG island in its promoter region in cancer tissues. However, the role of the methylation-induced RRAD inactivation in tumorigenesis remains unclear. In this study, the Ras-regulated transcriptome and epigenome were profiled by comparing T29H (a RasV12-transformed human ovarian epithelial cell line) with T29 (an immortalized but non-transformed cell line) through reduced representation bisulfite sequencing and digital gene expression. We found that RasV12-mediated oncogenic transformation was accompanied by RRAD promoter hypermethylation and a concomitant loss of RRAD expression. In addition, we found that the RRAD promoter was hypermethylated, and its transcription was reduced in ovarian cancer versus normal ovarian tissues. Treatment with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine resulted in demethylation in the RRAD promoter and restored RRAD expression in T29H cells. Additionally, treatment with farnesyltransferase inhibitor FTI277 resulted in restored RRAD expression and inhibited DNA methytransferase expression and activity in T29H cells. By employing knockdown and overexpression techniques in T29 and T29H, respectively, we found that RRAD inhibited glucose uptake and lactate production by repressing the expression of glucose transporters. Finally, RRAD overexpression in T29H cells inhibited tumor formation in nude mice, suggesting that RRAD is a tumor suppressor gene. Our results indicate that RasV12-mediated oncogenic transformation induces RRAD epigenetic inactivation, which in turn promotes glucose uptake and may contribute to ovarian cancer tumorigenesis. RRAD (Ras-related associated with diabetes) is a small Ras-related GTPase that is frequently inactivated by DNA methylation of the CpG island in its promoter region in cancer tissues. However, the role of the methylation-induced RRAD inactivation in tumorigenesis remains unclear. In this study, the Ras-regulated transcriptome and epigenome were profiled by comparing T29H (a RasV12-transformed human ovarian epithelial cell line) with T29 (an immortalized but non-transformed cell line) through reduced representation bisulfite sequencing and digital gene expression. We found that RasV12-mediated oncogenic transformation was accompanied by RRAD promoter hypermethylation and a concomitant loss of RRAD expression. In addition, we found that the RRAD promoter was hypermethylated, and its transcription was reduced in ovarian cancer versus normal ovarian tissues. Treatment with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine resulted in demethylation in the RRAD promoter and restored RRAD expression in T29H cells. Additionally, treatment with farnesyltransferase inhibitor FTI277 resulted in restored RRAD expression and inhibited DNA methytransferase expression and activity in T29H cells. By employing knockdown and overexpression techniques in T29 and T29H, respectively, we found that RRAD inhibited glucose uptake and lactate production by repressing the expression of glucose transporters. Finally, RRAD overexpression in T29H cells inhibited tumor formation in nude mice, suggesting that RRAD is a tumor suppressor gene. Our results indicate that RasV12-mediated oncogenic transformation induces RRAD epigenetic inactivation, which in turn promotes glucose uptake and may contribute to ovarian cancer tumorigenesis." @default.
• W2024890690 created "2016-06-24" @default.
• W2024890690 creator A5000948146 @default.
• W2024890690 creator A5002661428 @default.
• W2024890690 creator A5027650060 @default.
• W2024890690 creator A5028616197 @default.
• W2024890690 creator A5031052169 @default.
• W2024890690 creator A5035612207 @default.
• W2024890690 creator A5041703069 @default.
• W2024890690 creator A5046363705 @default.
• W2024890690 creator A5060333976 @default.
• W2024890690 creator A5064249883 @default.
• W2024890690 creator A5072289671 @default.
• W2024890690 creator A5078143614 @default.
• W2024890690 creator A5085028455 @default.
• W2024890690 creator A5091336301 @default.
• W2024890690 date "2014-05-01" @default.
• W2024890690 modified "2023-10-16" @default.
• W2024890690 title "Ras-induced Epigenetic Inactivation of the RRAD (Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model" @default.
• W2024890690 cites W1914707730 @default.
• W2024890690 cites W1978468109 @default.
• W2024890690 cites W1980958106 @default.
• W2024890690 cites W1990948801 @default.
• W2024890690 cites W1994468043 @default.
• W2024890690 cites W1999382524 @default.
• W2024890690 cites W2009127763 @default.
• W2024890690 cites W2011754232 @default.
• W2024890690 cites W2014058353 @default.
• W2024890690 cites W2015207840 @default.
• W2024890690 cites W2020232213 @default.
• W2024890690 cites W2022917224 @default.
• W2024890690 cites W2025419520 @default.
• W2024890690 cites W2031690321 @default.
• W2024890690 cites W2043201783 @default.
• W2024890690 cites W2052661726 @default.
• W2024890690 cites W2055551894 @default.
• W2024890690 cites W2059109318 @default.
• W2024890690 cites W2062475588 @default.
• W2024890690 cites W2065501752 @default.
• W2024890690 cites W2066848234 @default.
• W2024890690 cites W2072939418 @default.
• W2024890690 cites W2097259163 @default.
• W2024890690 cites W2099111050 @default.
• W2024890690 cites W2102099988 @default.
• W2024890690 cites W2105528101 @default.
• W2024890690 cites W2110015442 @default.
• W2024890690 cites W2113138323 @default.
• W2024890690 cites W2113588666 @default.
• W2024890690 cites W2114852376 @default.
• W2024890690 cites W2115212992 @default.
• W2024890690 cites W2117050753 @default.
• W2024890690 cites W2117510564 @default.
• W2024890690 cites W2123701599 @default.
• W2024890690 cites W2124985265 @default.
• W2024890690 cites W2125131431 @default.
• W2024890690 cites W2127101082 @default.
• W2024890690 cites W2132035843 @default.
• W2024890690 cites W2133705192 @default.
• W2024890690 cites W2139760555 @default.
• W2024890690 cites W2144720355 @default.
• W2024890690 cites W2146516445 @default.
• W2024890690 cites W2150070236 @default.
• W2024890690 cites W2151957217 @default.
• W2024890690 cites W2155279237 @default.
• W2024890690 cites W2157446482 @default.
• W2024890690 cites W2158774461 @default.
• W2024890690 cites W2417001068 @default.
• W2024890690 cites W4297067344 @default.
• W2024890690 doi "https://doi.org/10.1074/jbc.m113.527671" @default.
• W2024890690 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4022888" @default.
• W2024890690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24648519" @default.
• W2024890690 hasPublicationYear "2014" @default.
• W2024890690 type Work @default.
• W2024890690 sameAs 2024890690 @default.
• W2024890690 citedByCount "30" @default.
• W2024890690 countsByYear W20248906902015 @default.
• W2024890690 countsByYear W20248906902016 @default.
• W2024890690 countsByYear W20248906902017 @default.
• W2024890690 countsByYear W20248906902018 @default.
• W2024890690 countsByYear W20248906902019 @default.
• W2024890690 countsByYear W20248906902020 @default.
• W2024890690 countsByYear W20248906902021 @default.
• W2024890690 countsByYear W20248906902022 @default.
• W2024890690 countsByYear W20248906902023 @default.
• W2024890690 crossrefType "journal-article" @default.
• W2024890690 hasAuthorship W2024890690A5000948146 @default.
• W2024890690 hasAuthorship W2024890690A5002661428 @default.
• W2024890690 hasAuthorship W2024890690A5027650060 @default.
• W2024890690 hasAuthorship W2024890690A5028616197 @default.
• W2024890690 hasAuthorship W2024890690A5031052169 @default.
• W2024890690 hasAuthorship W2024890690A5035612207 @default.
• W2024890690 hasAuthorship W2024890690A5041703069 @default.
• W2024890690 hasAuthorship W2024890690A5046363705 @default.
• W2024890690 hasAuthorship W2024890690A5060333976 @default.
• W2024890690 hasAuthorship W2024890690A5064249883 @default.
• W2024890690 hasAuthorship W2024890690A5072289671 @default.
• W2024890690 hasAuthorship W2024890690A5078143614 @default.
• W2024890690 hasAuthorship W2024890690A5085028455 @default.

• next